
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fe(III)‐Shikonin Supramolecular Nanomedicine for Combined Therapy of Tumor via Ferroptosis and Necroptosis
Wenjie Feng, Wanrui Shi, Shuwei Liu, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 2
Closed Access | Times Cited: 66
Wenjie Feng, Wanrui Shi, Shuwei Liu, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 2
Closed Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 490
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 490
Recent progress of metal‐based nanomaterials with anti‐tumor biological effects for enhanced cancer therapy
Huali Lei, Zifan Pei, Chenyu Jiang, et al.
Exploration (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 98
Huali Lei, Zifan Pei, Chenyu Jiang, et al.
Exploration (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 98
Recent Progress of Supramolecular Chemotherapy Based on Host–Guest Interactions
Miaomiao Yan, Sha Wu, Yuhao Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 21
Closed Access | Times Cited: 96
Miaomiao Yan, Sha Wu, Yuhao Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 21
Closed Access | Times Cited: 96
Fe(III)‐Naphthazarin Metal–Phenolic Networks for Glutathione‐Depleting Enhanced Ferroptosis–Apoptosis Combined Cancer Therapy
Zhendong Liu, Sainan Liu, Bin Liu, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 70
Zhendong Liu, Sainan Liu, Bin Liu, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 70
Ferroptosis and Necroptosis Produced Autologous Tumor Cell Lysates Co-Delivering with Combined Immnoadjuvants as Personalized In Situ Nanovaccines for Antitumor Immunity
Wanrui Shi, Wenjie Feng, Siyuan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14475-14493
Closed Access | Times Cited: 48
Wanrui Shi, Wenjie Feng, Siyuan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14475-14493
Closed Access | Times Cited: 48
Nano-Drug Delivery Systems Based on Natural Products
Ying Lv, Wenqing Li, Wei Liao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 541-569
Open Access | Times Cited: 48
Ying Lv, Wenqing Li, Wei Liao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 541-569
Open Access | Times Cited: 48
Glutathione‐Scavenging Celastrol‐Cu Nanoparticles Induce Self‐Amplified Cuproptosis for Augmented Cancer Immunotherapy
Sheng Lü, Yifan Li, Yingjie Yu
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 46
Sheng Lü, Yifan Li, Yingjie Yu
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 46
Natural Products from Herbal Medicine Self‐Assemble into Advanced Bioactive Materials
Xiaohang Guo, Weikang Luo, Lingyu Wu, et al.
Advanced Science (2024)
Open Access | Times Cited: 42
Xiaohang Guo, Weikang Luo, Lingyu Wu, et al.
Advanced Science (2024)
Open Access | Times Cited: 42
Nanomedicine's shining armor: understanding and leveraging the metal-phenolic networks
Zhengming Tang, Zhijie Huang, Yisheng Huang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Zhengming Tang, Zhijie Huang, Yisheng Huang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Necroptosis pathways in tumorigenesis
Tao Zhang, Yingnan Wang, Hiroyuki Inuzuka, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 32-40
Open Access | Times Cited: 54
Tao Zhang, Yingnan Wang, Hiroyuki Inuzuka, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 32-40
Open Access | Times Cited: 54
Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification
Wenjie Feng, Wanrui Shi, Ze Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 33, pp. 37540-37552
Closed Access | Times Cited: 41
Wenjie Feng, Wanrui Shi, Ze Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 33, pp. 37540-37552
Closed Access | Times Cited: 41
Promising Nanomedicines of Shikonin for Cancer Therapy
Chunmei Yan, Qiuxia Li, Qiang Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1195-1218
Open Access | Times Cited: 37
Chunmei Yan, Qiuxia Li, Qiang Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1195-1218
Open Access | Times Cited: 37
Biomimetic dual-nanozymes with catalytic cascade reactions against diabetic wound infection
Siyuan Li, Yidi Zhang, Hao Jin, et al.
Journal of Colloid and Interface Science (2023) Vol. 651, pp. 319-333
Closed Access | Times Cited: 24
Siyuan Li, Yidi Zhang, Hao Jin, et al.
Journal of Colloid and Interface Science (2023) Vol. 651, pp. 319-333
Closed Access | Times Cited: 24
Tumor Microenvironment‐Activatable Metal‐Phenolic Nanoformulations for Ultrasound‐Boosted Ferroptosis through Triple Regulatory Pathways
Zhendong Liu, Sainan Liu, Bin Liu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 9
Zhendong Liu, Sainan Liu, Bin Liu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 9
Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity
Qinyanqiu Xiang, Xue Yang, Zhi‐Qi Zhang, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Qinyanqiu Xiang, Xue Yang, Zhi‐Qi Zhang, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Targeting necroptosis as an alternative strategy in tumor treatment: From drugs to nanoparticles
Xinlong Zang, Jinxiao Song, Yanfeng Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 213-226
Closed Access | Times Cited: 37
Xinlong Zang, Jinxiao Song, Yanfeng Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 213-226
Closed Access | Times Cited: 37
Engineered anti-cancer nanomedicine for synergistic ferroptosis-immunotherapy
Xinyu Zhang, Haiyan Ge, Yanling Ma, et al.
Chemical Engineering Journal (2022) Vol. 455, pp. 140688-140688
Closed Access | Times Cited: 33
Xinyu Zhang, Haiyan Ge, Yanling Ma, et al.
Chemical Engineering Journal (2022) Vol. 455, pp. 140688-140688
Closed Access | Times Cited: 33
Applications of metal–phenolic networks in nanomedicine: a review
Hanchi Wang, Dongyang Wang, Jize Yu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 20, pp. 5786-5808
Closed Access | Times Cited: 30
Hanchi Wang, Dongyang Wang, Jize Yu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 20, pp. 5786-5808
Closed Access | Times Cited: 30
Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination
Wenjie Feng, Wanrui Shi, Yanqi Cui, et al.
Theranostics (2023) Vol. 13, Iss. 15, pp. 5266-5289
Open Access | Times Cited: 18
Wenjie Feng, Wanrui Shi, Yanqi Cui, et al.
Theranostics (2023) Vol. 13, Iss. 15, pp. 5266-5289
Open Access | Times Cited: 18
Nanodrug Hijacking Blood Transferrin for Ferroptosis-Mediated Cancer Treatment
Shuyue Zhang, Xiao Wu, Xiaoming Liao, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8567-8575
Closed Access | Times Cited: 8
Shuyue Zhang, Xiao Wu, Xiaoming Liao, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8567-8575
Closed Access | Times Cited: 8
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance
Bifei Fu, YuMing Lou, Pu Wu, et al.
Neoplasia (2024) Vol. 55, pp. 101017-101017
Open Access | Times Cited: 8
Bifei Fu, YuMing Lou, Pu Wu, et al.
Neoplasia (2024) Vol. 55, pp. 101017-101017
Open Access | Times Cited: 8
An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy
Jingbo Ma, Haitao Yuan, Jingjing Zhang, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 501-515
Closed Access | Times Cited: 7
Jingbo Ma, Haitao Yuan, Jingjing Zhang, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 501-515
Closed Access | Times Cited: 7
Metal-coordinated nanodrugs based on natural products for cancer theranostics
Shuang Liu, Xiuping Xu, Jin Ye, et al.
Chemical Engineering Journal (2022) Vol. 456, pp. 140892-140892
Closed Access | Times Cited: 24
Shuang Liu, Xiuping Xu, Jin Ye, et al.
Chemical Engineering Journal (2022) Vol. 456, pp. 140892-140892
Closed Access | Times Cited: 24
Fe-doped carbon dots: a novel biocompatible nanoplatform for multi-level cancer therapy
Mingxi Yang, Haiqiu Li, Xinchen Liu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Mingxi Yang, Haiqiu Li, Xinchen Liu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Ultrafast self-assembled supramolecular nanoparticles for enhanced chemodynamic therapy and ferroptosis through lactic acid metabolism regulation
Qi Meng, Jia Tan, Weifang Tong, et al.
Chemical Engineering Journal (2023) Vol. 471, pp. 144563-144563
Open Access | Times Cited: 15
Qi Meng, Jia Tan, Weifang Tong, et al.
Chemical Engineering Journal (2023) Vol. 471, pp. 144563-144563
Open Access | Times Cited: 15